EVCDX-MODERNA-MERCK-CANCER-ECFFC8
Moderna, Merck cancer vaccine shows initial late-stage melanoma data
Contract: 0x1C813d4b18b49dF6a210D0fd68ECb60c12ae37de
EVCDX-MODERNA-MERCK-CANCER-ECFFC8 is the tokenized index of the event card “Moderna, Merck cancer vaccine shows initial late-stage melanoma data”. The card takes positions in its underlying assets — stocks, cryptos, options and perps — and the token's value moves with those positions. Merck and Moderna's experimental personalized cancer vaccine showed positive initial results in its first-ever late-stage trial: the mRNA-based shot, combined with Merck's immunotherapy Keytruda, met key goals in a phase three trial of more than 1,100 patients with higher-risk melanoma that had been fully removed by surgery.
NAV Statistics
NAV per token
$1.13
NAV updated
2026-08-21 12:51 UTC
Price-weighted level
18.01
Card index (base 100 at launch)
113.19
Holdings
| Asset | Symbol | Price | Weight |
|---|---|---|---|
| BNTX Selected and weighted by the Tuatara connection engine for this theme. |
BNTX | $110.50 | 64.75% |
| SLS Selected and weighted by the Tuatara connection engine for this theme. |
SLS | $13.37 | 9.15% |
| CADL Selected and weighted by the Tuatara connection engine for this theme. |
CADL | $12.45 | 8.41% |
| INKT Selected and weighted by the Tuatara connection engine for this theme. |
INKT | $11.62 | 8.38% |
| CYCN Selected and weighted by the Tuatara connection engine for this theme. |
CYCN | $4.07 | 2.88% |
| BCTX Selected and weighted by the Tuatara connection engine for this theme. |
BCTX | $4.05 | 2.46% |
| CGEN Selected and weighted by the Tuatara connection engine for this theme. |
CGEN | $2.60 | 1.66% |
| HURA Selected and weighted by the Tuatara connection engine for this theme. |
HURA | $2.26 | 1.51% |
| MRKR Selected and weighted by the Tuatara connection engine for this theme. |
MRKR | $1.22 | 0.80% |
1M Performance (trailing 30 days — the Card index measures since launch)
Aug 19
+0.85%
Aug 21